Should a follow-up repeat the original pitch?

No. Repeat the reason you're relevant in one sentence, then add something new: a proof point, a tighter ask, or a way out. Replaying the first email makes you look automated. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it weird to email someone after six months of silence?

Not if you have a new reason and you don't pretend the old thread is still warm. Lead with the trigger, remind them who you are in one line, and make the ask optional. Nostalgia without news is just another cold email with extra steps.

Is it okay to send this follow-up on LinkedIn instead of email?

Yes if this CTO is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals follow-up?

Don't use consumer-startup slang. It's a credibility leak. Calling it 'AI-powered' with no description of the system. Don't open with 'it's been a while' and then paste the old pitch. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Can I use aggressive sales language in pharma outreach?

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · CTO · Long Time No Contact

Follow-Up for Pharmaceuticals CTO: Long Time No Contact

A follow-up email is a short, context-rich message that reconnects after an earlier touch without restating the whole pitch. For Pharmaceuticals teams, the version that works for long time no contact has to respect Don't invent clinical claims. Write to the CTO like they already have a full calendar and a reason to be cautious.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this follow-up work for a Pharmaceuticals CTO?

Swap a meeting ask for a smaller yes when they went quiet.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a CTO actually reads: 90 words is plenty if the substance is real. Don't pad.
Bring a new observation about their world, then offer a small, optional next step.
Restate the original reason in one line so they don't hunt the thread.

When should I send this to a Pharmaceuticals CTO?

Give it 3 to 5 business days after the last note before you ping again. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a CTO, 90 words is plenty if the substance is real. Don't pad.

What this CTO actually cares about

A CTO in Pharmaceuticals is protecting reliability, security, and engineering time. They look for architecture, failure modes, and whether you'll create toil for their team. Fluff is a ranking signal that you don't know the work. The hook that earns a look is an incident class, a security gap, or a cost line they already hate. The ask should stay at this size: a technical working session or a written teardown, not a 'vision call'. Delete trigger: Calling it 'AI-powered' with no description of the system. They protect reliability, security, and engineering time, so keep the ask at "a technical working session or a written teardown, not a 'vision call'."

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Launch calendars and review boards set speed. You don't. Words that work: MLR, label, access, HCP, congress, promotional review.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone precise.
Change the subject if the original thread looks dead in their inbox.
Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this long time no contact note?

The fastest way to get ignored is stacking three asks into one nudge.
Don't open with 'it's been a while' and then paste the old pitch.
Don't use consumer-startup slang. It's a credibility leak.
Calling it 'AI-powered' with no description of the system.

How does this long time no contact scenario compare?

Dimension	For this template
Best send window	Only when you have a trigger
Ideal length	90 words is plenty if the substance is real. Don't pad.
Primary ask	a technical working session or a written teardown, not a 'vision call'
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Precise. No slogans. It's fine to be a little dry.
Unlike no response	This isn't a 4-day bump. It's a re-introduction with a new reason.
Unlike breakup	You're opening a door, not closing one. Still keep it easy to ignore.

What should I copy and send?

Copy-ready template

Subject

One detail I forgot to mention

Body

Hi [First Name],

Bumping this once in case it landed under something louder.

The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. I sent a note on follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick and didn't want it to die in the pile. Here's the 15-second version: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft.

Bring a new observation about their world, then offer a small, optional next step.

If it's a no for now, just say so and I'll stop pinging.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Give it 3 to 5 business days after the last note before you ping again. Send when you have a real trigger: news, a useful artifact, a role change, a season. After that, send a breakup note and archive it. A CTO who wants it will answer a clean close more often than a fifth bump.

Related templates

Want a custom draft instead? Try the email generator.